Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Non-Current Debt (2016 - 2025)

Surgery Partners' Non-Current Debt history spans 12 years, with the latest figure at $3.6 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 10.22% year-over-year to $3.6 billion; the TTM value through Dec 2025 reached $3.6 billion, up 10.22%, while the annual FY2025 figure was $3.6 billion, 10.22% up from the prior year.
  • Non-Current Debt for Q4 2025 was $3.6 billion at Surgery Partners, up from $3.5 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $3.6 billion in Q4 2025 and bottomed at $2.5 billion in Q2 2023.
  • The 5-year median for Non-Current Debt is $2.9 billion (2021), against an average of $3.0 billion.
  • The largest annual shift saw Non-Current Debt fell 17.04% in 2023 before it rose 23.38% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $2.9 billion in 2021, then dropped by 11.1% to $2.6 billion in 2022, then increased by 5.58% to $2.7 billion in 2023, then rose by 20.99% to $3.3 billion in 2024, then increased by 10.22% to $3.6 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Non-Current Debt are $3.6 billion (Q4 2025), $3.5 billion (Q3 2025), and $3.5 billion (Q2 2025).